Natco Pharma has received Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA) for the inspection conducted at its drug formulations facility in Kothur Village, Telangana, India, during the period May 30, 2019-June 5, 2019.
Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.